Patent 10005772 was granted and assigned to 3M on June, 2018 by the United States Patent and Trademark Office.
The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.